Elgomhouria Pharmaceutical
Elgomhouria Pharmaceutical, often referred to as Elgomhouria, is a prominent player in the pharmaceutical industry, headquartered in Egypt (EG). Established in 1995, the company has made significant strides in the development and distribution of high-quality pharmaceutical products across the Middle East and North Africa (MENA) region. Specialising in a diverse range of therapeutic areas, Elgomhouria is known for its innovative formulations and commitment to quality. The company’s core offerings include prescription medications, over-the-counter products, and specialised healthcare solutions, all designed to meet the evolving needs of patients and healthcare providers. With a strong market presence and a reputation for excellence, Elgomhouria Pharmaceutical continues to achieve notable milestones, solidifying its position as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Elgomhouria Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elgomhouria Pharmaceutical's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Elgomhouria Pharmaceutical's reported carbon emissions
Elgomhouria Pharmaceutical, headquartered in Egypt (EG), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of publicly available information may reflect a broader industry context where many pharmaceutical companies are increasingly focusing on sustainability and carbon reduction initiatives. As the industry evolves, it is anticipated that Elgomhouria Pharmaceutical may develop and disclose its climate strategies and commitments in the future, aligning with global trends towards enhanced environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elgomhouria Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
